(Q46961293)

26 December 2017

editorial

0 references

title

The withdrawal of torcetrapib from drug development: implications for the future of drugs that alter HDL metabolism (English)

1 reference

26 December 2017

author name string

Laurence G Howes

series ordinal

1

1 reference

26 December 2017

Karam Kostner

series ordinal

2

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

26 December 2017

Expert Opinion on Investigational Drugs

published in

1 reference

26 December 2017

volume

16

1 reference

26 December 2017

issue

10

1 reference

26 December 2017

page(s)

1509-1516

1 reference

26 December 2017

Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Effect of HDL, from Japanese white rabbit administered a new cholesteryl ester transfer protein inhibitor JTT-705, on cholesteryl ester accumulation induced by acetylated low density lipoprotein in J774 macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Effect of torcetrapib on the progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

New insights into the biogenesis of human high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Endothelial and antithrombotic actions of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

HDL cholesterol transport during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.10.1509

10.1517/13543784.16.10.1509

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017